TCL Archive Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall June 5, 2009
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014